Strategy question

What strategies are Apple, Amazon, and Google taking in healthcare? What is better, breadth or depth in healthcare use cases? Pros/cons?

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Tests market and competitive strategy analysis across multiple real companies, weighing a breadth-versus-depth tradeoff with reasoned pros and cons.

Characterize each company's actual approach: Apple focuses on consumer health/wearables depth (Watch, Health app), Amazon on infrastructure and pharmacy breadth (PillPack, Amazon Clinic), Google on data/AI depth (DeepMind Health, Fitbit).
Define breadth: covering many healthcare touchpoints (pharmacy, insurance, provider) versus depth: owning one vertical extremely well (e.g. wearable-based monitoring).
Lay out breadth's pros: more revenue surface and stickiness, cons: regulatory complexity multiplies and execution risk rises across many fronts.
Lay out depth's pros: easier regulatory and clinical focus, strong differentiation, cons: smaller addressable revenue and vulnerable to a broader competitor.
Give a reasoned recommendation: depth first to build clinical credibility and trust, then expand breadth once a strong wedge is proven, rather than doing both at once.

Grounds the analysis in real, verifiable strategic moves (Apple Watch, Amazon Pharmacy/PillPack, Google/Fitbit) instead of generic healthcare speculation.
Gives explicit pros and cons for both breadth and depth rather than declaring one universally better.
Recommends a sequenced strategy, depth-first for trust then breadth, showing nuanced reasoning over a flat pick.
Notes healthcare's unique regulatory and trust burden makes breadth riskier here than in typical tech expansion, a domain-specific insight.

Stating a preference (breadth or depth) without concrete pros and cons for each.
Ignoring the regulatory and trust dimension that makes healthcare strategy fundamentally different from typical product expansion.

Which of these three companies do you think is best positioned long-term, and why?
How would regulatory risk change your recommendation?